# Frovatriptan and Menstrual Migraine

> **NCT01114711** · — · TERMINATED · sponsor: **Mclean Hospital** · enrollment: 24 (actual)

## Conditions studied

- Frovatriptan
- Menstrual Migraine

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01114711
- **Lead sponsor:** Mclean Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2010-04
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** A sister study using Frova at a 10 mg dose had adverse effects.
- **Last updated:** 2018-04-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01114711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01114711, "Frovatriptan and Menstrual Migraine". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01114711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*